Histide
Schindellegi, CH · 1 known investors
Histide is a biotech intellectual property platform company developing a class of non-mutagenic extracellular therapeutic agents called Cell Recoding Molecules (CRM), which act on the cell's microenvironment to redirect cell fate for tissue regeneration and disease treatment. Its Recoding Therapeutics platform targets applications across pharmaceuticals, medical devices, and medical cosmetics, with a pipeline spanning five strategic therapeutic areas.
Investors · 1
Frequently asked questions
- What does Histide do?
- Histide is a biotech intellectual property platform company developing a class of non-mutagenic extracellular therapeutic agents called Cell Recoding Molecules (CRM), which act on the cell's microenvironment to redirect cell fate for tissue regeneration and disease treatment. Its Recoding Therapeutics platform targets applications across pharmaceuticals, medical devices, and medical cosmetics, with a pipeline spanning five strategic therapeutic areas.
- Who are Histide's investors?
- Histide's investors include Open Field Capital.
- Where is Histide headquartered?
- Histide is headquartered in Schindellegi, CH.